Trial Profile
Effects of candesartan cilexetil versus calcium channel antagonists on arterial stiffness in hypertensive patients with metabolic syndrome
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 02 Feb 2011
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Calcium channel antagonists
- Indications Hypertension
- Focus Pharmacodynamics
- 02 Feb 2011 New trial record